3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
5
Genitourinary
3
CNS
3
Gastrointestinal
2
Dermatologic
2
Other solid neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
226
Lymphoma
221
Lymphoma, Non-Hodgkin
194
Leukemia, Lymphocytic, Chronic, B-Cell
175
Lymphoma, Large B-Cell, Diffuse
170
Lymphoma, Follicular
164
Lymphoma, B-Cell
108
Lymphoma, Mantle-Cell
102
Hodgkin Disease
99
Recurrence
94
Leukemia, Myeloid, Acute
94
Multiple Myeloma
89
Burkitt Lymphoma
86
Leukemia
76
Neoplasms
66
Hematologic Neoplasms
58
Lymphoma, B-Cell, Marginal Zone
56
Myelodysplastic Syndromes
52
Waldenstrom Macroglobulinemia
42
Lymphoma, T-Cell
42
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
37
Lymphoma, T-Cell, Peripheral
35
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Biphenotypic, Acute
28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
27
Leukemia, B-Cell
27
Mycosis Fungoides
25
Lymphoma, Large-Cell, Anaplastic
25
Sarcoma
24
Lymphoproliferative Disorders
20
Interventions
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
Lymphoid
×
90 days
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled